Skip to content
2000
Volume 13, Issue 3
  • ISSN: 1573-403X
  • E-ISSN: 1875-6557

Abstract

Background: Statins have long been used for the protection against coronary artery disease (CAD). Their beneficial effect apart from cholesterol reduction lies in their pleiotropic properties. Emerging evidence from laboratory studies and clinical trials as well have pointed out the pivotal role of inflammation on the initiation and exacerbation of atherosclerosis; a major cause of CAD. Inflammation markers such as high sensitivity C-reactive protein and adhesion molecules are shown to increase in CAD patients and are used as prognostic tools. It is well known that statins can actually reduce the circulating levels of these agents slowing therefore the inflammatory process; interestingly not all types have the same outcome. Conclusion: The anti-inflammatory effect of statins on the formation of atherosclerotic plaque and the function of endothelial cells is thus of particular importance as these agents can actually ameliorate CAD prognosis.

Loading

Article metrics loading...

/content/journals/ccr/10.2174/1573403X13666170426104611
2017-08-01
2025-09-24
Loading full text...

Full text loading...

/content/journals/ccr/10.2174/1573403X13666170426104611
Loading

  • Article Type:
    Research Article
Keyword(s): CAD prognosis; coronary artery disease; CRP; inflammation; pleiotropic effect; Statins
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test